Literature DB >> 29200103

BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.

Adrián Mariño-Enriquez1, Alexandra Lauria1, Joanna Przybyl2, Tony L Ng3, Magdalena Kowalewska4,5, Maria Debiec-Rychter6, Raji Ganesan7, Vaiyapuri Sumathi8, Suzanne George9, W Glenn McCluggage10, Marisa R Nucci1, Cheng-Han Lee11, Jonathan A Fletcher1.   

Abstract

Endometrial stromal sarcomas (ESSs) are mesenchymal uterine tumors characterized by recurrent genetic events, most commonly chromosomal rearrangements, that create oncogenic gene fusions. High-grade endometrial stromal sarcomas (HG-ESSs), as defined in the 2014 World Health Organization Classification, typically contain oncogenic YWHAE-NUTM2 fusions; however, although not well characterized, there are tumors morphologically overlapping with HG-ESS that do not contain the YWHAE-NUTM2 fusions. These fusions are also found in certain pediatric primitive sarcomas, including clear cell sarcoma of the kidney and soft tissue undifferentiated round cell sarcoma of infancy. A subset of these same pediatric sarcomas lack YWHAE-NUTM2 fusions and instead have internal tandem duplications (ITDs) involving exon 15 of BCOR (BCOR ITD). We investigated the presence of BCOR ITD by targeted sequencing in a series of 31 uterine sarcomas, comprising 5 low-grade ESS, 13 uterine sarcomas diagnosed as HG-ESS, and 13 undifferentiated uterine sarcomas. BCOR ITD were present in 1 uterine sarcoma diagnosed as HG-ESS and 2 undifferentiated sarcomas with uniform nuclear features, all of which lacked any of the recurrent chromosome translocations known to occur in ESS. These 3 high-grade sarcomas with BCOR ITD affected young patients (average age, 24) and morphologically were composed of nonpleomorphic spindle cells admixed with epithelioid and round cell areas. Focal myxoid stroma was present in 2 cases. Mitotic activity was brisk, necrosis was present, and there was lymphovascular involvement in all cases. The 3 uterine sarcomas with BCOR ITD exhibited diffuse cyclin D1 immunohistochemical expression and there was diffuse BCOR expression in the 2 cases tested. Long-term follow-up in 2 patients revealed 1 to be tumor-free after 22 years and the other to die of disease after 8 years. In conclusion, BCOR ITD is an oncogenic alternative to YWHAE-NUTM2 fusion in high-grade uterine sarcomas with uniform nuclear features. We propose that neoplasms with the morphology described and BCOR ITD be regarded as a unique subtype of high-grade uterine sarcoma, possibly within the family of endometrial stromal neoplasia.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29200103     DOI: 10.1097/PAS.0000000000000993

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

1.  DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.

Authors:  Felix K F Kommoss; Damian Stichel; Daniel Schrimpf; Mark Kriegsmann; Basile Tessier-Cloutier; Aline Talhouk; Jessica N McAlpine; Kenneth T E Chang; Dominik Sturm; Stefan M Pfister; Laura Romero-Pérez; Thomas Kirchner; Thomas G P Grünewald; Rolf Buslei; Hans-Peter Sinn; Gunhild Mechtersheimer; Peter Schirmacher; Dietmar Schmidt; Hans-Anton Lehr; Felix Sahm; David G Huntsman; C Blake Gilks; Friedrich Kommoss; Andreas von Deimling; Christian Koelsche
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-25       Impact factor: 4.553

Review 2.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

3.  PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.

Authors:  Sarah Chiang; Wesley Samore; Lei Zhang; Yun-Shao Sung; Gulisa Turashvili; Rajmohan Murali; Robert A Soslow; Martee L Hensley; David Swanson; Brendan C Dickson; Colin J R Stewart; Esther Oliva; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

Review 4.  [Current WHO classification of the female genitals : Many new things, but also some old].

Authors:  Doris Mayr; Elisa Schmoeckel; Anne Kathrin Höhn; Grit Gesine Ruth Hiller; Lars-Christian Horn
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

5.  Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.

Authors:  Paolo Cotzia; Ryma Benayed; Kerry Mullaney; Esther Oliva; Ana Felix; Joana Ferreira; Robert A Soslow; Cristina R Antonescu; Marc Ladanyi; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2019-05       Impact factor: 6.394

6.  Pleomorphic high grade endometrial stromal sarcoma with YWHAE gene amplification may be a novel variant with poor prognosis.

Authors:  Asad Ullah; Haritha Arbindi; Francis Zola; Samantha Nieves Mattox; Luis Velasquez Zarate; Janet Munroe; Saleh Heneidi; Suash Sharma; Sharad Ghamande; Daniel T Kleven
Journal:  Int J Clin Exp Pathol       Date:  2022-02-15

7.  Error-prone, stress-induced 3' flap-based Okazaki fragment maturation supports cell survival.

Authors:  Haitao Sun; Zhaoning Lu; Amanpreet Singh; Yajing Zhou; Eric Zheng; Mian Zhou; Jinhui Wang; Xiwei Wu; Zunsong Hu; Zhaohui Gu; Judith L Campbell; Li Zheng; Binghui Shen
Journal:  Science       Date:  2021-12-02       Impact factor: 47.728

8.  A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene.

Authors:  Anastasios Kyriazoglou; Natalia Tourkantoni; Michalis Liontos; Flora Zagouri; Louisa Mahaira; Alexandra Papakosta; Dimitra Michali; Amalia Patereli; Kalliopi Stefanaki; Vasiliki Tzotzola; Evangelia Skoura; Margarita Baka; Sofia Polychronopoulou; Antonis Kattamis; Efthymios Dimitriadis
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

9.  Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.

Authors:  Amir Momeni-Boroujeni; Nissreen Mohammad; Robert Wolber; Stephen Yip; Martin Köbel; Brendan C Dickson; Martee L Hensley; Mario M Leitao; Cristina R Antonescu; Ryma Benayed; Marc Ladanyi; Cheng-Han Lee; Sarah Chiang
Journal:  Mod Pathol       Date:  2020-10-19       Impact factor: 7.842

10.  Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.

Authors:  Pier Selenica; Niamh Conlon; Carlene Gonzalez; Denise Frosina; Achim A Jungbluth; Regina G H Beets-Tan; Mamta K Rao; Yanming Zhang; Ryma Benayed; Marc Ladanyi; David B Solit; Sarah Chiang; David M Hyman; Martee L Hensley; Robert A Soslow; Britta Weigelt; Rajmohan Murali
Journal:  Am J Surg Pathol       Date:  2021-01       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.